AEGR-733 News
Most Popular AEGR-733 Story
Aegerion compound lowers cholesterol, weight
Aegerion Pharmaceuticals announced that preliminary data indicates positive results for three separate phase II trials involving the company's lead cholesterol candidate, AEGR-733--a microsomal Read more...
Latest Headlines
- November 6, 2008
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
